Conflicting Evidence Of mRNA Technology Raises Serious Concerns About Rush For Use In New Vaccine Development

Authored by Megan Redshaw via The Epoch Times, FRIDAY, SEP 01, 2023 The U.S. government and pharmaceutical companies are investing a substantial amount to develop new mRNA vaccines for infectious…[...]

Read More

Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)

Jim M Wild1, Joanna C Porter2,3,4, Philip L Molyneaux5,6, Peter M George5,6, http://orcid.org/0000-0002-1340-2688Iain Stewart5, Richard James Allen7, Raminder Aul8, http://orcid.org/0000-0001-5258-793XJohn Kenneth Baillie9, Shaney L Barratt10, Paul Beirne11, Stephen M Bianchi12, John F Blaikley13,14, Jonathan Brooke15,16,17, http://orcid.org/0000-0003-3325-6996Nazia Chaudhuri14,18, Guilhem Collier1, http://orcid.org/0000-0002-7695-325XEmma K Denneny2,3,4, Annemarie Docherty19, http://orcid.org/0000-0002-8250-6464Laura Fabbri5, Michael…[...]

Read More